Literature DB >> 16167882

The role of bystander T cells in CNS pathology and pathogen clearance.

Dorian B McGavern1.   

Abstract

It is generally accepted that both self- and pathogen-specific T lymphocytes have the potential to mediate immunopathogenesis and contribute to a variety of human ailments. Despite this unfortunate tendency to induce tissue injury, these cells are guided by interactions with peptide-loaded major histocompatibility complexes (MHC) and adhere appropriately to a vital evolutionary constraint imposed by the host: specificity. More recently, a series of studies have demonstrated that bystander T cells of an irrelevant specificity can bypass peptide/MHC restriction and become active participants in immunopathology. This review critically evaluates the role of bystander T cells in immunopathogenesis and pathogen clearance in the periphery as well as the central nervous system and attempts to establish the likelihood of their participation in human disease.

Entities:  

Mesh:

Year:  2005        PMID: 16167882      PMCID: PMC5292138          DOI: 10.1615/critrevimmunol.v25.i4.30

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  116 in total

Review 1.  HIV-1 pathogenesis.

Authors:  Mario Stevenson
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 2.  Reflections on CD8 T-cell activation and memory.

Authors:  David Masopust; Rafi Ahmed
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Septic shock: pathogenesis.

Authors:  M P Glauser; G Zanetti; J D Baumgartner; J Cohen
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

4.  Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection.

Authors:  S Gangappa; S P Deshpande; B T Rouse
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

5.  Large clonal expansions of CD8+ T cells in acute infectious mononucleosis.

Authors:  M F Callan; N Steven; P Krausa; J D Wilson; P A Moss; G M Gillespie; J I Bell; A B Rickinson; A J McMichael
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

Review 6.  Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

Authors:  Maher K Gandhi; Rajiv Khanna
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

7.  Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes.

Authors:  Julie Cabarrocas; Jan Bauer; Eliane Piaggio; Roland Liblau; Hans Lassmann
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

8.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

Review 9.  No one is naive: the significance of heterologous T-cell immunity.

Authors:  Raymond M Welsh; Liisa K Selin
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

Review 10.  Molecular mimicry and immune-mediated diseases.

Authors:  M B Oldstone
Journal:  FASEB J       Date:  1998-10       Impact factor: 5.191

View more
  6 in total

1.  Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells that are distinct from protective populations.

Authors:  Rebeccah S Lijek; Jennifer D Helble; Andrew J Olive; Kyra W Seiger; Michael N Starnbach
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-09       Impact factor: 11.205

Review 2.  The role of antiviral CD8+ T cells in cognitive impairment.

Authors:  Katie L Reagin; Kristen E Funk
Journal:  Curr Opin Neurobiol       Date:  2022-07-08       Impact factor: 7.070

3.  Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system.

Authors:  Russell Maxwell; Andrew S Luksik; Tomas Garzon-Muvdi; Alice L Hung; Eileen S Kim; Adela Wu; Yuanxuan Xia; Zineb Belcaid; Noah Gorelick; John Choi; Debebe Theodros; Christopher M Jackson; Dimitrios Mathios; Xiaobu Ye; Phuoc T Tran; Kristin J Redmond; Henry Brem; Drew M Pardoll; Lawrence R Kleinberg; Michael Lim
Journal:  Oncoimmunology       Date:  2018-09-06       Impact factor: 8.110

4.  T cells can mediate viral clearance from ependyma but not from brain parenchyma in a major histocompatibility class I- and perforin-independent manner.

Authors:  Daniel D Pinschewer; Mariann Schedensack; Andreas Bergthaler; Edit Horvath; Wolfgang Brück; Max Löhning; Doron Merkler
Journal:  Brain       Date:  2010-03-30       Impact factor: 13.501

5.  Molecular anatomy and number of antigen specific CD8 T cells required to cause type 1 diabetes.

Authors:  Michael B A Oldstone; Kurt H Edelmann; Dorian B McGavern; Justin T Cruite; Megan J Welch
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

Review 6.  The great balancing act: regulation and fate of antiviral T-cell interactions.

Authors:  E Ashley Moseman; Dorian B McGavern
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.